
    
      Evaluation of severe symptom control of nausea, vomiting, postprandial fullness, early
      satiety, bloating and discomfort related to drug refractory gastroparesis present as a GI
      complication in diabetic patients. External gastric pacemaker system will be placed at the
      same time of implantation of Enterra (internal gastric stimulator-permanent device) to assess
      symptoms, quality of life improvement and investigate the changes in gastric emptying time in
      diabetic gastroparesis.
    
  